Literature DB >> 18362136

Expression, purification, and characterization of the immunological response to a 40-kilodalton Plasmodium vivax tryptophan-rich antigen.

Asim A Siddiqui1, Hema Bora, Neeru Singh, Aditya P Dash, Yagya D Sharma.   

Abstract

We describe here an approximately 40-kDa Plasmodium vivax tryptophan-rich antigen (PvTRAg40) which contains 321 amino acids and 11.4% tryptophan residues. This protein shows 65% homology (35% identity) with the previously described PvTRAg, besides sharing 23 of 27 positionally conserved tryptophan residues and similar genomic organization. The nucleotide sequence of the entire tryptophan-rich domain of PvTRAg40 was identical among 35 P. vivax clinical isolates. The protein is expressed by ring, trophozoite, and schizont stages of the parasite. The cDNA covering exon 2 of PvTRAg40 was cloned and expressed in the pPROEXHTa vector, and recombinant protein was purified. A high humoral immune response (90.7% seropositivity; n = 43) against this recombinant protein was detected in humans during the course of natural P. vivax infection. Eighty percent of the total of 20 P. vivax-exposed individuals exhibited lymphoproliferative responses against this antigen. The T cells of these individuals produced larger amounts of interleukin-12 (IL-12), IL-4, and IL-10 than gamma interferon and tumor necrosis factor alpha cytokines in response to the recombinant protein. Production of Th2-biased cytokines, conserved T- and B-cell epitopes, and an enhanced humoral immune response indicate that PvTRAg40 could possibly induce antibody-mediated immune protection against infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362136      PMCID: PMC2423051          DOI: 10.1128/IAI.00677-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Non-CS pre-erythrocytic protective antigens.

Authors:  M R Hollingdale; M Aikawa; C T Atkinson; W R Ballou; G X Chen; J Li; J F Meis; B Sina; C Wright; J D Zhu
Journal:  Immunol Lett       Date:  1990-08       Impact factor: 3.685

Review 2.  Development of a malaria vaccine.

Authors:  D Kwiatkowski; K Marsh
Journal:  Lancet       Date:  1997-12-06       Impact factor: 79.321

3.  A novel Plasmodium falciparum sporozoite and liver stage antigen (SALSA) defines major B, T helper, and CTL epitopes.

Authors:  E Bottius; L BenMohamed; K Brahimi; H Gras; J P Lepers; L Raharimalala; M Aikawa; J Meis; B Slierendregt; A Tartar; A Thomas; P Druilhe
Journal:  J Immunol       Date:  1996-04-15       Impact factor: 5.422

Review 4.  The neglected burden of Plasmodium vivax malaria.

Authors:  K Mendis; B J Sina; P Marchesini; R Carter
Journal:  Am J Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.345

5.  T-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic.

Authors:  M Connelly; C L King; K Bucci; S Walters; B Genton; M P Alpers; M Hollingdale; J W Kazura
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

6.  Expression and purification of HtpX-like small heat shock integral membrane protease of an unknown organism related to Methylobacillus flagellatus.

Authors:  Asim A Siddiqui; Rashmi Jalah; Yagya D Sharma
Journal:  J Biochem Biophys Methods       Date:  2006-12-19

Review 7.  T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages.

Authors:  E H Nardin; R S Nussenzweig
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

8.  Plasmodium vivax: immune responses in a cross-section of the population in the Delhi area of India.

Authors:  P Ray; M A Ansari; Y D Sharma
Journal:  Am J Trop Med Hyg       Date:  1994-10       Impact factor: 2.345

9.  IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism.

Authors:  M M Stevenson; M F Tam; S F Wolf; A Sher
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

10.  Regulation of the immune response in Plasmodium falciparum malaria. III. Proliferative response to antigen in vitro and subset composition of T cells from patients with acute infection or from immune donors.

Authors:  M Troye-Blomberg; P Romero; M E Patarroyo; A Björkman; P Perlmann
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

View more
  7 in total

1.  Promiscuous T-cell epitopes of Plasmodium merozoite surface protein 9 (PvMSP9) induces IFN-gamma and IL-4 responses in individuals naturally exposed to malaria in the Brazilian Amazon.

Authors:  J C Lima-Junior; D M Banic; T M Tran; V S E Meyer; S G De-Simone; F Santos; L C S Porto; M T Q Marques; A Moreno; J W Barnwell; M R Galinski; J Oliveira-Ferreira
Journal:  Vaccine       Date:  2010-02-26       Impact factor: 3.641

2.  CD4+ T cell response correlates with naturally acquired antibodies against Plasmodium vivax tryptophan-rich antigens.

Authors:  Mohammad Zeeshan; Kriti Tyagi; Yagya D Sharma
Journal:  Infect Immun       Date:  2015-03-02       Impact factor: 3.441

3.  Erythrocyte Binding Activity Displayed by a Selective Group of Plasmodium vivax Tryptophan Rich Antigens Is Inhibited by Patients' Antibodies.

Authors:  Rupesh Kumar Tyagi; Yagya Dutta Sharma
Journal:  PLoS One       Date:  2012-12-06       Impact factor: 3.240

4.  Plasmodium vivax tryptophan-rich antigen PvTRAg33.5 contains alpha helical structure and multidomain architecture.

Authors:  Hema Bora; Sheena Garg; Priyankar Sen; Deepak Kumar; Punit Kaur; Rizwan Hasan Khan; Yagya D Sharma
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

5.  Naturally-acquired cellular immune response against Plasmodium vivax merozoite surface protein-1 paralog antigen.

Authors:  Siriruk Changrob; Chaniya Leepiyasakulchai; Takafumi Tsuboi; Yang Cheng; Chae Seung Lim; Patchanee Chootong; Eun-Taek Han
Journal:  Malar J       Date:  2015-04-15       Impact factor: 2.979

6.  Defining the erythrocyte binding domains of Plasmodium vivax tryptophan rich antigen 33.5.

Authors:  Hema Bora; Rupesh Kumar Tyagi; Yagya Dutta Sharma
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

7.  Host-parasite interaction: multiple sites in the Plasmodium vivax tryptophan-rich antigen PvTRAg38 interact with the erythrocyte receptor band 3.

Authors:  Mohd S Alam; Sumit Rathore; Rupesh K Tyagi; Yagya D Sharma
Journal:  FEBS Lett       Date:  2016-01-23       Impact factor: 4.124

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.